Insider Transactions in Q1 2025 at Pacira Bio Sciences, Inc. (PCRX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 01
2025
|
Lauren Bullaro Riker Senior Vice President, Finance |
BUY
Grant, award, or other acquisition
|
Direct |
30,600
+30.87%
|
-
|
|
Feb 01
2025
|
Brendan Teehan Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
54,000
+50.0%
|
-
|
|
Feb 01
2025
|
Frank D. Lee Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
350,000
+43.84%
|
-
|
|
Feb 01
2025
|
Kristen Marie Williams Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
79,200
+30.31%
|
-
|
|
Feb 01
2025
|
Jonathan Slonin Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
93,600
+33.35%
|
-
|
|
Jan 06
2025
|
Jonathan Slonin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
879
-0.93%
|
$15,822
$18.4 P/Share
|
|
Jan 02
2025
|
Lauren Bullaro Riker Senior Vice President, Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
159
-0.42%
|
$2,862
$18.33 P/Share
|
|
Jan 02
2025
|
Jonathan Slonin Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
371
-0.39%
|
$6,678
$18.33 P/Share
|
|
Jan 02
2025
|
Frank D. Lee Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,375
-8.7%
|
$168,750
$18.33 P/Share
|